Literature DB >> 7694023

Clinical aspects of hepatitis B virus infection.

T L Wright1, J Y Lau.   

Abstract

Entities:  

Keywords:  Adult; Age Factors; Biology; Blood Supply; Chronic Diseases; Delivery Of Health Care; Demographic Factors; Diseases; Drugs; Equipment And Supplies; Health; Health Services; Hepatic Effects; Hepatitis--transmission; Histology; Hiv Infections; Immunization; Infections; Liver Cirrhosis; Liver Neoplasms; Neoplasms; Obstacles; Organization And Administration; Physiology; Population; Population Characteristics; Primary Health Care; Reproductive Tract Infections; Sexually Transmitted Diseases; Signs And Symptoms; Treatment; Vaccination; Viral Diseases

Mesh:

Substances:

Year:  1993        PMID: 7694023     DOI: 10.1016/0140-6736(93)92250-w

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  37 in total

1.  Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence.

Authors:  P Seiler; B M Senn; P Klenerman; U Kalinke; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Blockade of neutrophil elastase attenuates severe liver injury in hepatitis B transgenic mice.

Authors:  Shinji Takai; Kiminori Kimura; Masahito Nagaki; Shinichi Satake; Kazuhiro Kakimi; Hisataka Moriwaki
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 3.  Induced immunity against hepatitis B virus.

Authors:  Zeinab Nabil Ahmed Said; Kouka Saadeldin Abdelwahab
Journal:  World J Hepatol       Date:  2015-06-28

4.  Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif.

Authors:  Hiromi Yatsuji; Chiemi Noguchi; Nobuhiko Hiraga; Nami Mori; Masataka Tsuge; Michio Imamura; Shoichi Takahashi; Eiji Iwao; Yoshifumi Fujimoto; Hidenori Ochi; Hiromi Abe; Toshiro Maekawa; Chise Tateno; Katsutoshi Yoshizato; Fumitaka Suzuki; Hiromitsu Kumada; Kazuaki Chayama
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

5.  The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro.

Authors:  C T Bock; N P Malek; H L Tillmann; M P Manns; C Trautwein
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 6.  Targeted DNA mutagenesis for the cure of chronic viral infections.

Authors:  Joshua T Schiffer; Martine Aubert; Nicholas D Weber; Esther Mintzer; Daniel Stone; Keith R Jerome
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

7.  Influencing factors of transient elastography in detecting liver stiffness.

Authors:  Rong Shan; Hong Yin; Wenjuan Yang; Jianzhi Li; Meifang Zhang; Min Zhao; Jiang Shao; Aiguang Wang
Journal:  Exp Ther Med       Date:  2016-08-24       Impact factor: 2.447

Review 8.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

Review 9.  Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.

Authors:  Wen-Lung Ma; Hsueh-Chou Lai; Shuyuan Yeh; Xiujun Cai; Chawnshang Chang
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

10.  Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus.

Authors:  Nahed Ismail; Geoffrey E Fish; Michael B Smith
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.